Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma

Medulloblastoma is the most common malignant childhood brain tumor, and 5-year overall survival rates are as low as 40% depending on molecular subtype, with new therapies critically important. As radiotherapy and chemotherapy act through the induction of DNA damage, the sensitization of cancer cells...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Mol Biosci
Päätekijät: Buck, Jessica, Dyer, Patrick J. C., Hii, Hilary, Carline, Brooke, Kuchibhotla, Mani, Byrne, Jacob, Howlett, Meegan, Whitehouse, Jacqueline, Ebert, Martin A., McDonald, Kerrie L., Gottardo, Nicholas G., Endersby, Raelene
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Molecular Biosciences
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8116896/
https://ncbi.nlm.nih.gov/pubmed/33996894
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmolb.2021.633344
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia